Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Petros Sfikakis
Institutions:
National and Kapodistrian University of Athens,
Laiko General Hospital of Athens
Observed institutions:
National and Kapodistrian University of Athens,
Laiko General Hospital of Athens
ORCID:
0000-0001-5484-2930
Observed ORCID:
0000-0001-5484-2930
OpenAlex ID:
A5124776045
Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritis
2026
·
George A Karpouzas
, Virginia Pascual-Ramos
, et al.
·
RMD Open
·
1
PDF
Proton pump inhibitor use and long-term outcomes in SSc: a real-life analysis from the EUSTAR database
2026
·
Francesco Bonomi
, Giulia Bandini
, et al.
·
Lara D. Veeken
P25 - ECE_3587 - Ordinary circadian rhythm and physiological variation of diurnal salivary cortisol levels in healthy young adults
2026
·
Dimitra Adamou
, Anastasia Evangelatou
, et al.
·
European Journal of Endocrinology
PDF
OC.26 Which anti-centromere antibody–positive systemic sclerosis patients are less likely to develop organ involvement? Insights from the EUSTAR cohort
2026
·
Jelena Colic
, Corrado Campochiaro
, et al.
PDF
P.281 Real-life observational study to evaluate raynaud’s severity and the change in digital ulcers in Greek patients with systemic sclerosis treated with bosentan. The cure study
2026
·
Katerina Laskari
, Dimitrios Vassilopoulos
, et al.
·
Poster presentations
OC.06 Elevated mortality linked to myocardial fibrosis in systemic sclerosis: a multicenter CMR study in autoimmune rheumatic diseases
2026
·
Ibolya Csecs
, Maciej Tysarowski
, et al.
PDF
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database
2026
·
Florian Käs
, Muriel Elhai
, et al.
·
Journal of Autoimmunity
Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritis
2026
·
George A Karpouzas
, Miguel A Gonzalez-Gay
, et al.
·
RMD Open
PDF
Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study
2026
·
Laure Gossec
, Xenofon Baraliakos
, et al.
·
Rheumatology and Therapy
PDF
Show more works
View as search
Works count:
9
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type